CN106387915A - 杞咖益元泡腾片及其制备工艺和应用 - Google Patents
杞咖益元泡腾片及其制备工艺和应用 Download PDFInfo
- Publication number
- CN106387915A CN106387915A CN201611035080.XA CN201611035080A CN106387915A CN 106387915 A CN106387915 A CN 106387915A CN 201611035080 A CN201611035080 A CN 201611035080A CN 106387915 A CN106387915 A CN 106387915A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- agent
- effervescent tablet
- coffee
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007938 effervescent tablet Substances 0.000 title claims abstract description 93
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 239000000284 extract Substances 0.000 claims abstract description 97
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 88
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 61
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 61
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 61
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 49
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 48
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 47
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 47
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 39
- 150000004676 glycans Chemical class 0.000 claims abstract description 38
- 239000005017 polysaccharide Substances 0.000 claims abstract description 38
- 239000002253 acid Substances 0.000 claims abstract description 23
- 239000011248 coating agent Substances 0.000 claims abstract description 20
- 239000003085 diluting agent Substances 0.000 claims abstract description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 139
- 239000000843 powder Substances 0.000 claims description 114
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 92
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 53
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 46
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 46
- 235000015165 citric acid Nutrition 0.000 claims description 44
- 240000007154 Coffea arabica Species 0.000 claims description 43
- 235000016213 coffee Nutrition 0.000 claims description 43
- 235000013353 coffee beverage Nutrition 0.000 claims description 43
- 230000008901 benefit Effects 0.000 claims description 42
- 239000008118 PEG 6000 Substances 0.000 claims description 35
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 28
- 239000011734 sodium Substances 0.000 claims description 27
- 239000002671 adjuvant Substances 0.000 claims description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 25
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 22
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 22
- 238000005516 engineering process Methods 0.000 claims description 22
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 22
- 229940013618 stevioside Drugs 0.000 claims description 22
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 22
- 235000019202 steviosides Nutrition 0.000 claims description 22
- 239000000811 xylitol Substances 0.000 claims description 22
- 235000010447 xylitol Nutrition 0.000 claims description 22
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 22
- 229960002675 xylitol Drugs 0.000 claims description 22
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 20
- 239000008119 colloidal silica Substances 0.000 claims description 19
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 17
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 17
- 229910052708 sodium Inorganic materials 0.000 claims description 17
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 16
- 238000007908 dry granulation Methods 0.000 claims description 16
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 15
- 239000008107 starch Substances 0.000 claims description 15
- 235000019698 starch Nutrition 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 229910001220 stainless steel Inorganic materials 0.000 claims description 12
- 239000010935 stainless steel Substances 0.000 claims description 12
- 235000002906 tartaric acid Nutrition 0.000 claims description 12
- 239000011975 tartaric acid Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 10
- 239000000796 flavoring agent Substances 0.000 claims description 10
- 235000013355 food flavoring agent Nutrition 0.000 claims description 10
- 239000001530 fumaric acid Substances 0.000 claims description 10
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 10
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 9
- 239000013543 active substance Substances 0.000 claims description 9
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 9
- 230000003340 mental effect Effects 0.000 claims description 9
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 9
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 9
- 235000002710 Ilex cornuta Nutrition 0.000 claims description 7
- 241001310146 Ilex cornuta Species 0.000 claims description 7
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 229960004106 citric acid Drugs 0.000 claims description 6
- -1 filtration Substances 0.000 claims description 6
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 claims description 5
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical group C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 229960000913 crospovidone Drugs 0.000 claims description 5
- 238000004132 cross linking Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- 244000099147 Ananas comosus Species 0.000 claims description 3
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 229940109275 cyclamate Drugs 0.000 claims description 3
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- 206010061598 Immunodeficiency Diseases 0.000 claims description 2
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 claims description 2
- 235000011087 fumaric acid Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229940083542 sodium Drugs 0.000 claims description 2
- 235000009392 Vitis Nutrition 0.000 claims 1
- 241000219095 Vitis Species 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 49
- 230000008569 process Effects 0.000 abstract description 20
- 239000008518 lycium barbarum polysaccharide Substances 0.000 abstract description 19
- 230000036039 immunity Effects 0.000 abstract description 11
- 230000002708 enhancing effect Effects 0.000 abstract description 10
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 239000003513 alkali Substances 0.000 abstract description 4
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009835 boiling Methods 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 238000001291 vacuum drying Methods 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 63
- 239000000047 product Substances 0.000 description 42
- 230000000694 effects Effects 0.000 description 32
- 239000003826 tablet Substances 0.000 description 25
- 206010016256 fatigue Diseases 0.000 description 20
- 239000003814 drug Substances 0.000 description 19
- 238000011160 research Methods 0.000 description 17
- 239000008187 granular material Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000013112 stability test Methods 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 230000003064 anti-oxidating effect Effects 0.000 description 11
- 230000033228 biological regulation Effects 0.000 description 10
- 230000036541 health Effects 0.000 description 10
- 238000007689 inspection Methods 0.000 description 10
- 238000007789 sealing Methods 0.000 description 10
- 238000013461 design Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 8
- 238000005303 weighing Methods 0.000 description 8
- 238000007907 direct compression Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000010298 pulverizing process Methods 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000012567 medical material Substances 0.000 description 6
- 238000007493 shaping process Methods 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000004574 high-performance concrete Substances 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000001013 cariogenic effect Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000007891 compressed tablet Substances 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 230000002519 immonomodulatory effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 238000012858 packaging process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000002992 thymic effect Effects 0.000 description 2
- 230000003867 tiredness Effects 0.000 description 2
- 208000016255 tiredness Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000554155 Andes Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 244000211187 Lepidium sativum Species 0.000 description 1
- 235000007849 Lepidium sativum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- FSBUXLDOLNLABB-ISAKITKMSA-N echinacoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FSBUXLDOLNLABB-ISAKITKMSA-N 0.000 description 1
- NJYVDFDTLLZVMG-UHFFFAOYSA-N echinacoside Natural products CC1OC(OC2C(O)C(OCCc3ccc(O)c(O)c3)OC(COC4OC(CO)C(O)C(O)C4O)C2OC(=O)C=Cc5cc(O)cc(O)c5)C(O)C(O)C1O NJYVDFDTLLZVMG-UHFFFAOYSA-N 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008125 glucin Substances 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- XPPXHQUWVYMTDM-UHFFFAOYSA-N nicoclonate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)OC(=O)C1=CC=CN=C1 XPPXHQUWVYMTDM-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
水平因素 | A 柠檬酸(%) | B 碳酸氢钠(%) | C PEG6000(%) |
1 | 10.0 | 15.7 | 3.0 |
2 | 12.0 | 13.1 | 4.0 |
3 | 14.0 | 10.5 | 5.0 |
方差来源 | 方差平方和 | 自由度 | 均方 | F | 显著性 |
A | 8720.2222 | 2 | 4360.1111 | 22.31 | 显著 |
B | 295366.8889 | 2 | 147683.4444 | 755.63 | 高度显著 |
C | 410.8889 | 2 | 205.4444 | 1.05 | 不显著 |
误差 | 390.8889 | 2 | 195.4444 | ||
总和 | 304888.8889 | 8 |
方差来源 | 方差平方和 | 自由度 | 均方 | F | 显著性 |
A | 5.0042 | 2 | 2.5021 | 32.96 | 显著 |
B | 6.0652 | 2 | 3.0326 | 39.95 | 显著 |
C | 6.9528 | 2 | 3.4764 | 45.79 | 显著 |
误差 | 0.1518 | 2 | 0.0759 | ||
总和 | 18.1741 | 8 |
方差来源 | 方差平方和 | 自由度 | 均方 | F | 显著性 |
A | 0.1406 | 2 | 0.0703 | 12.05 | 不显著 |
B | 1.1467 | 2 | 0.5733 | 98.29 | 显著 |
C | 0.2451 | 2 | 0.1225 | 21.01 | 显著 |
误差 | 0.0117 | 2 | 0.0058 | ||
总和 | 1.5440 | 8 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611035080.XA CN106387915B (zh) | 2016-11-23 | 2016-11-23 | 杞咖益元泡腾片及其制备工艺和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611035080.XA CN106387915B (zh) | 2016-11-23 | 2016-11-23 | 杞咖益元泡腾片及其制备工艺和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106387915A true CN106387915A (zh) | 2017-02-15 |
CN106387915B CN106387915B (zh) | 2021-12-28 |
Family
ID=58081522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611035080.XA Active CN106387915B (zh) | 2016-11-23 | 2016-11-23 | 杞咖益元泡腾片及其制备工艺和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106387915B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116869109A (zh) * | 2023-07-20 | 2023-10-13 | 广东润和生物科技有限公司 | 一种强效抗氧化辅酶q10泡腾片及其制备工艺 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050186319A1 (en) * | 2004-02-20 | 2005-08-25 | Formed, Inc. | Method and composition for fortifying a single serving prepared beverage having minimal nutritional value |
CN1698664A (zh) * | 2004-05-21 | 2005-11-23 | 江西本草天工科技有限责任公司 | 板蓝根泡腾片及制备方法 |
CN1733246A (zh) * | 2005-09-07 | 2006-02-15 | 北京因科瑞斯生物制品研究所 | 一种金莲清热泡腾片及其制备方法 |
CN103961469A (zh) * | 2014-05-23 | 2014-08-06 | 汤臣倍健股份有限公司 | 中药组合物及其应用、保健品及其制备方法 |
US20140271492A1 (en) * | 2013-03-15 | 2014-09-18 | Mylan Inc. | Manufacturing Process for Effervescent Dosage Forms |
CN105079466A (zh) * | 2014-05-16 | 2015-11-25 | 华中科技大学 | 一种金线莲泡腾片及其制备方法 |
CN105685617A (zh) * | 2014-11-28 | 2016-06-22 | 方端 | 一种玛咖、冬虫夏草、灵芝提取物泡腾片 |
CN105876589A (zh) * | 2016-04-27 | 2016-08-24 | 佛山市聚成生化技术研发有限公司 | 一种具有调节免疫力功效的泡腾片饮料 |
CN105994792A (zh) * | 2016-05-24 | 2016-10-12 | 安徽源和堂药业股份有限公司 | 一种虫草菌液养生泡腾茶饮片 |
-
2016
- 2016-11-23 CN CN201611035080.XA patent/CN106387915B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050186319A1 (en) * | 2004-02-20 | 2005-08-25 | Formed, Inc. | Method and composition for fortifying a single serving prepared beverage having minimal nutritional value |
CN1698664A (zh) * | 2004-05-21 | 2005-11-23 | 江西本草天工科技有限责任公司 | 板蓝根泡腾片及制备方法 |
CN1733246A (zh) * | 2005-09-07 | 2006-02-15 | 北京因科瑞斯生物制品研究所 | 一种金莲清热泡腾片及其制备方法 |
US20140271492A1 (en) * | 2013-03-15 | 2014-09-18 | Mylan Inc. | Manufacturing Process for Effervescent Dosage Forms |
CN105079466A (zh) * | 2014-05-16 | 2015-11-25 | 华中科技大学 | 一种金线莲泡腾片及其制备方法 |
CN103961469A (zh) * | 2014-05-23 | 2014-08-06 | 汤臣倍健股份有限公司 | 中药组合物及其应用、保健品及其制备方法 |
CN105685617A (zh) * | 2014-11-28 | 2016-06-22 | 方端 | 一种玛咖、冬虫夏草、灵芝提取物泡腾片 |
CN105876589A (zh) * | 2016-04-27 | 2016-08-24 | 佛山市聚成生化技术研发有限公司 | 一种具有调节免疫力功效的泡腾片饮料 |
CN105994792A (zh) * | 2016-05-24 | 2016-10-12 | 安徽源和堂药业股份有限公司 | 一种虫草菌液养生泡腾茶饮片 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116869109A (zh) * | 2023-07-20 | 2023-10-13 | 广东润和生物科技有限公司 | 一种强效抗氧化辅酶q10泡腾片及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN106387915B (zh) | 2021-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106174485A (zh) | 具有强肾壮阳功效的酵素组合物、泡腾片及制备方法 | |
CN102008528A (zh) | 复方海参制剂及其制备方法 | |
CN111035649B (zh) | 一种nmn+glp复配营养补充剂及其制备方法和应用 | |
CN101152007A (zh) | 一种保健品组合物及其制备方法 | |
CN102907604A (zh) | 一种降糖、降压、减肥、通便养颜、抗疲劳保健品及其生产工艺 | |
CN105360824B (zh) | 一种虫草饮料及其制备方法 | |
CN102526477B (zh) | 一种增强免疫力的药物组合物及其制备方法和应用 | |
CN106723015A (zh) | 一种具有抗疲劳和抗氧化功能的保健食品及其制备工艺 | |
CN102258679B (zh) | 一种中药组合物、制备方法及其应用 | |
CN106039050A (zh) | 一种益生菌发酵玉米须的组合物及其制备方法和应用 | |
CN101019645B (zh) | 一种缓解疲劳和提高缺氧耐受力的保健食品及其制备方法 | |
CN106214845A (zh) | 一种具有保健功能的药物组合物及其制备方法 | |
CN108785412B (zh) | 一种具有改善睡眠功能的组合物及其制备方法 | |
CN101108225A (zh) | 一种治疗糖尿病的胶囊剂及制备工艺 | |
CN106387915A (zh) | 杞咖益元泡腾片及其制备工艺和应用 | |
CN106666703A (zh) | 具有保肝护肝功效的酵素组合物、制剂及制备方法 | |
CN103610048B (zh) | 对化学性肝损伤有辅助保护功能的保健食品及其制备方法 | |
CN113694078B (zh) | 醋炙五味子多糖提取物在制备治疗糖尿病的药物中的应用 | |
CN104127816B (zh) | 一种治疗糖尿病的药物组合物及其制备方法和用途 | |
CN109620913B (zh) | 一种预防和/或治疗肥胖、高血糖的组合物 | |
CN112076292A (zh) | 一种具有增强免疫力和调节肾阴虚功能的粉剂及其制备方法 | |
AU2021101743A4 (en) | Preparation Method of Polygonatum sibiricum Tea Bag Combined with Exercise for Prevention and Adjuvant Therapy for Hyperglycemia | |
CN116392567B (zh) | 一种改善睾丸功能障碍的中药组合物及其制备方法和应用 | |
CN112544973B (zh) | 一种辅助降血脂组合物,由其制备的复方颗粒以及制备方法和用途 | |
CN114425066B (zh) | 缓解体力疲劳的组合物、药品、食品或保健品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 750002 Room 1118, Building 5, Wanda Plaza, Jinyuan North Street, Jinfeng District, Yinchuan City, Ningxia Hui Autonomous Region Applicant after: Ningxia five line Technology Co., Ltd. Applicant after: Ningxia Xixia Health Technology Co., Ltd. Address before: 753600 East and North of Hongli Road Extension Section, Huinong District, Shizuishan City, Ningxia Hui Autonomous Region Applicant before: Ningxia Xixia Health Technology Co., Ltd. Applicant before: Ningxia five line Technology Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |